Crossmark

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)

Crossref DOI link: https://doi.org/10.1038/s41409-023-01981-x

Published Online: 2023-04-12

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gomez-Arteaga, Alexandra https://orcid.org/0000-0003-0897-3790
Orfali, Nina https://orcid.org/0000-0001-7203-7580
Pasciolla, Michelle

Baptiste, Ayanna

Guindine, Inna

Hsu, Jingmei

Lin, Jonathan

Mayer, Sebastian A.

Phillips, Adrienne A.

Shore, Tsiporah B. https://orcid.org/0000-0001-6033-0747
Simonson, Paul D. https://orcid.org/0000-0001-6237-6861
DiCarlo, Edward

Yoon, Sung

Muthukumar, Thangamani

van Besien, Koen
License Information

Text and Data Mining valid from 2023-04-12

Version of Record valid from 2023-04-12
More Information

Article History

Received: 28 February 2023

Revised: 21 March 2023

Accepted: 28 March 2023

First Online: 12 April 2023

Competing interests

: The authors declare no competing interests.

: The patient provided informed consent for publication.

Document is current

Any future updates will be listed below